Registry following children in China with rheumatic and immune diseases
Records long-term health of children under 18 with autoimmune conditions.
Plain-language title generated from the registry record
Registry title: Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Key facts
- Where
- Beijing, Changsha, Chongqing, Hangzhou, Nanjing, and Shenzhen, ChinaSee the 9 sites
Where in China
- Beijing Children's Hospital, Capital Medical UniversityBeijing, ChinaTaking people
- Peking Union Medical College HospitalBeijing, ChinaTaking people
- Third Hospital of Peking UniversityBeijing, ChinaTaking people
- The Second Xiangya Hospital of Central South UniversityChangsha, ChinaTaking people
- Chidren's Hospital of Chongqing Medical UniversityChongqing, ChinaTaking people
- Children's Hospital of Zhejiang University School of MedicineHangzhou, ChinaTaking people
- Children's Hospital of Nanjing Medical UniversityNanjing, ChinaTaking people
- Shenzhen Children's HospitalShenzhen, ChinaTaking people
- The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI)Shenzhen, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peking Union Medical College Hospital
- Trial code
- NCT06417502
- Record updated
- 16 May 2024
- Original description
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.Read full original descriptionShow less
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.
Inclusion: Age <= 18 years old; Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity); Diagnosed and Treated in China.
Exclusion: Disagreement of involving in this study by the patient or his/her family.